Standard drugs for hepatitis C virus are less likely to knock out the infection in black patients than in whites, finds a study in the May 27 New England Journal of Medicine.
Hepatitis C is a liver ailment that afflicts roughly 4 million people in the United States.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.